Published
9 months agoon
Good morning, Bull Sheeters. Investors have hit pause on this incredible stocks rally with Asia and Europe down this morning. U.S. futures are also in the red.
But that’s after the Nasdaq hit yet another all-time high yesterday, and the S&P 500 has now battled back to within 1.6% of break-even for 2020. It’s also after the U.S. topped 130,000 coronavirus deaths. And it comes as too many frazzled parents have no idea if America’s schools will fully reopen in September, and companies wonder which state or city will be the next to close down bars, restaurants and businesses. The uncertainty feels like an all-time high, too.
Let’s check in on today’s action.
***
Let’s talk earnings. ‘Tis the season, after all.
Next week is the first big week on the quarterly reporting calendar with JP Morgan Chase, Bank of America and Wells Fargo all scheduling analyst calls. It should give us, in many cases, the clearest picture yet of the economic destruction from the quarter that just passed—Q2.
Beginning three months ago, we got a startling number of companies pulling guidance, so much of what we hear will truly be new. Investors, so far, have gone easy on companies for their EPS misses. The big question remains: does earnings-per-share even matter this year, or will some other metric emerge to determine the fitness of companies in the age of COVID? Perhaps it will be cash flow or debt levels or top-line growth.
Now, let’s look back at Q1. For many (non-tech) companies, it was a brutal quarter that nevertheless will look better than what we’re about to hear.
Taken in aggregate, S&P 500 companies saw the top- (sales) and bottom lines (earnings) fall quarter-on-quarter, as this BofA breakdown shows:
There was just one exception to that. Health care outperformed all other segments in both earnings and sales in Q1. (If you had thought it would be tech, you’re not alone.)
But there’s a big disconnect between business performance and share price. YTD, the best performing S&P sector, shares-wise, is not health care. Yep, it’s tech. Health care is trading nearly flat—up just 0.7% in 2020—while tech is up nearly 17%.
That makes some sense. Investors mostly look forward, so share price tends to more heavily reflect future performance. Hence, investors are betting that tech is the sector best positioned to weather this crisis, and to grow in the post-COVID economy as well.
But is the recent run-up in tech stocks truly justified? Here’s where these earnings calls are important. We’ll begin to see which of these high-flyers are the next great hope, and which are nothing but hype.
***
Have a nice day, everyone. I’ll see you here tomorrow.
Bernhard Warner
@BernhardWarner
Bernhard.Warner@Fortune.com
A note from my Fortune colleagues on a timely new initiative:
Many companies are speaking out against racial injustices right now. But how do they fare in their own workplaces? Black employees in the corporate world, we want to hear from you: Please submit your anonymous thoughts and anecdotes here. https://bit.ly/WorkingWhileBlack
As always, you can write to bullsheet@fortune.com or reply to this email with suggestions and feedback.